View in EDS

Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort.

Saved in:
Bibliographic Details
Title: Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort.
Authors: Rha, Sun Young1 (AUTHOR) rha7655@yuhs.ac, Castanon, Eduardo2 (AUTHOR), Gill, Sanjeev3 (AUTHOR), Senellart, Helene4 (AUTHOR), Lopez, Juanita5 (AUTHOR), Márquez‐Rodas, Iván6 (AUTHOR), Victoria, Iván7 (AUTHOR), Kim, Tae Min8 (AUTHOR), Lwin, Zarnie9 (AUTHOR), Burger, Michael C.10 (AUTHOR), Simonelli, Matteo11,12 (AUTHOR), Cassier, Philippe A.13 (AUTHOR), Hendifar, Andrew E.14 (AUTHOR), Ascierto, Paolo A.15 (AUTHOR), Dutcus, Corina16 (AUTHOR), Okpara, Chinyere E.17 (AUTHOR), Ghori, Razi18 (AUTHOR), Jin, Fan18 (AUTHOR), Groisberg, Roman18 (AUTHOR), Villanueva, Luis19 (AUTHOR)
Source: Cancer (0008543X). Aug2025, Vol. 131 Issue 16, p1-12. 12p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.70015